| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |